RxDoctor Payments DataLook up a doctor →

BASAGLAR: payments to doctors

Payments that named BASAGLAR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$912K
Providers
22,431
Transactions
71,283
Average per transaction
$13

The per-transaction average — $13 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 22,431 providers the average total is $41, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Lilly USA, LLC$908,95399.7%
Eli Lilly$3,0450.3%
← All drugs & devices